Meetings

The IHC Network Presents 

​

The Utility of Immunohistochemistry in  Malignant Melanoma 

 

Tuesday 25th February 7 – 8:30pm GMT 

​

Online Meeting 

In our first webinar for 2025, we discuss the important and necessary uses of Immunohistochemistry in Malignant Melanoma’s. Join us for 3 excellent presentations and the chance for discussion. 

​

Meeting Programme: 

7:00 -7:05pm Welcome and introduction

Keeley Thwaites/Colin Tristram, The IHC Network 

​

7:05 -7:25pm AMBLor - a novel biomarker for cutaneous melanoma

Prof Phil Sloan, AMLo Biosciences. 

​

7:25-7:45pm Melanoma markers and quality control

Colin Tristram, Histocyte Laboratories and The IHC Network. 

​

7:45-8:05pm The Expression of PRAME in Melanocytic Lesions 

Karolina Wojcik, The Institute of Dermatology, Guy’s and St. Thomas’ NHS NHS foundation Trust.

​